Epilepsy and Menopause: What This Clinical Guide Covers

What was studied

This clinical guide reviewed published research and used expert consensus to address epilepsy care during menopause. It focused on how hormonal changes, antiseizure medicines, menopausal treatments, and related health risks may affect women with epilepsy.

No specific group of participants was enrolled because this was a literature review and expert guide, not a new clinical trial.

What they found

The guide reports that women with epilepsy may be at increased risk of early menopause, cardiovascular disease, osteoporosis, and cognitive impairment compared with women without epilepsy. Hormonal changes and medicine interactions may influence seizure susceptibility and treatment needs.

Systemic menopausal hormone therapy may be considered when its potential benefits outweigh its risks. The authors suggest that estrogen delivered through the skin may be preferred to minimize dose-related fluctuations in hormone levels. Potential interactions between antiseizure medicines and systemic hormone therapy should be considered, and changes to antiseizure treatment may sometimes be necessary. The guide recommends personalized care and multidisciplinary healthcare teams.

Limits of the evidence

Evidence is limited because women with epilepsy are often excluded from randomized controlled trials and observational studies of menopausal symptoms and osteoporosis treatments. The abstract does not provide details about the number, size, quality, or findings of the studies reviewed. The guide also draws on expert opinion, reflecting the limited available evidence.

For families and caregivers

Menopause may affect seizure susceptibility, treatment needs, and longer-term health in women with epilepsy. This guide supports assessing epilepsy and menopausal health together. Decisions about systemic hormone therapy should be personalized, taking account of potential benefits, risks, and interactions with antiseizure medicines.

What to watch next

Further studies that include women with epilepsy are needed to clarify the optimal management of menopausal symptoms and osteoporosis in this population.

Terms in this summary

Antiseizure medicine

A medicine used to prevent or reduce seizures.

Menopausal hormone therapy

Treatment using hormones, usually estrogen with or without a progestogen, to manage menopausal symptoms.

Systemic therapy

Treatment that travels through the bloodstream and affects the body more broadly.

Transdermal estrogen

Estrogen delivered through the skin, usually by a patch, gel, or spray.

Osteoporosis

A condition in which bones become weaker and more likely to break.

Cardiovascular disease

Disease involving the heart or blood vessels.

Expert consensus

Recommendations based on agreement among specialists, especially when research evidence is limited.

Multidisciplinary team

Healthcare professionals from different specialties working together on a person's care.